Right Ventricular Function and Respiratory Acidosis After Cardiac Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLaval University

About this trial

Right heart dysfunction remains a frequent cause of morbidity and mortality after cardiac surgery. Respiratory acidosis, particularly when accompanied by hypoxemia, plays a significant role in right heart failure, primarily by increasing right ventricular afterload through pulmonary vasoconstriction and elevated pulmonary arterial pressures. This phenomenon leads to increased right ventricular workload, causing dilation, decreased contractility, and ultimately right heart failure. The study aims to evaluate the effect of respiratory acidosis on right ventricular function after cardiac surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Previously included and complete study NCT05886413 or NCT06826794

Disqualifiers

Absence of one or more of the following hemodynamic measurements: systolic or diastolic pulmonary artery pressure, central venous pressure, cardiac output

Absence of arterial blood gas on arrival to the intensive care unit

Trial population

Adult patients who underwent cardiac surgery mechanically ventilated in controlled mode, and had an arterial blood gas within the first hour following admission.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Not applicable- observational study

    Other intervention

    No intervention

Treatment groups

220 Participants
are divided into 2 treatment groups
Group A: Retrospective cohort1 intervention
Group B: Prospective cohort1 intervention

Trial outcomes

Primary outcomes

1

Right ventricular function per central hemodynamic assessment

Calculation of different predictor: Cardiac index, PAPi (pulmonary artery pulse pressure over central venous pressure) , RVSWI ((mean pulmonary artery pressure- central venous pressure) X stroke volume index X 0.0136) and RV-CPO

Time frame
At intensive care unit admission - within the first 4 hours

Secondary outcomes

1

Intensive care unit length of stay

Intensive care unit admission through Intensive care unit discharge

Time frame
Up to 28 days
2

Mechanical ventilation duration

Time spent with invasive mechanical ventilation between intensive care unit admission and hospital discharge

Time frame
Day 28
3

Vasopressor duration

Duration of vasopressor or inotrope administration

Time frame
Day 28
4

Acute renal failure

Rate of acute renal failure during coronary unit length of stay. Renal failure will be defined according to the usual criteria, i.e., an increase of \>27 umol/L creatinine in 48 hours or 1.5x over the baseline

Time frame
Day 28

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: